Pharmaceutical News

RSS

Dieters experience drops in basal metabolic rate, in spite of daily exercise

The International Association for the Study of Obesity has bad news for dieters: as reported in the New York Times, the commonly held belief that exercise is a magic metabolism booster may be largely unfounded. A new study finds that people who lost weight experienced drops in basal metabolic rate (BMR), in spite of daily exercise.

8 Aug 2012

New class of drugs reduces adverse effects of cellular damage from cancer chemotherapy

Chemotherapy kills tumor cells, but it also wreaks havoc on the rest of the body. A team of researchers led by Igor Roninson of the South Carolina College of Pharmacy just reported the discovery of a new class of drugs that reduces the adverse effects of cellular damage from chemotherapy.

8 Aug 2012

Review explores whether HPV vaccination of young men is warranted and cost effective

Vaccination against human papilloma virus (HPV) is recommended for young women to protect them from HPV infection and cervical cancer. Male HPV immunization is increasingly a topic of debate in the medical community. A timely review of the literature published in Viral Immunology, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers, explores whether HPV vaccination of young men is warranted and cost effective.

8 Aug 2012

Older men with higher levels of free testosterone more likely to develop prostate cancer

New research finds older men with higher levels of free testosterone have an increased risk of prostate cancer. Australian researchers spent a decade exploring the testosterone-prostate cancer connection by comparing natural testosterone levels of men in their 70s and 80s, those with prostate cancer and without.

8 Aug 2012

BioDiem granted European patent for antimicrobial drug

Australian vaccine development company BioDiem Ltd (ASX: BDM) announced today the successful granting of a key European patent for its synthetic antimicrobial compound BDM-I. BDM-I is a novel compound active against a range of pathogenic micro-organisms including bacteria, fungi and protozoa. The patent provides protection around BDM-I as a treatment for vulvovaginitis, a general term for inflammation of the vulva or vagina.

7 Aug 2012

Mylan receives final FDA approval for Montelukast Sodium Tablets ANDA

Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Montelukast Sodium Tablets, 10 mg, the generic version of Merck's Singulair Tablets.

7 Aug 2012

Cannabis-based medications prove effective in relieving pain

Cannabis-based medications have been proved to relieve pain. This is the conclusion drawn by Franjo Grotenhermen and Kirsten Müller-Vahl in issue 29-30 of Deutsches Ärzteblatt International.

7 Aug 2012

NCH conducts workshop to teach participants how and when to use EpiPen

Many children with severe allergies carry injectable epinephrine (EpiPens) - syringes filled with epinephrine to delay an allergic reaction - but the EpiPens sometimes require the help of an adult to dispense. School nurses are often the only school officials authorized to handle medications, leaving the educators who are with the children most of the day untrained. According to doctors at Nationwide Children's Hospital, this lack of training is exactly what becomes most dangerous for children with severe allergies.

7 Aug 2012

Scientists discover biological marker that may help identify patients’ response to antidepressants

Scientists have discovered a biological marker that may help to identify which depressed patients will respond to an experimental, rapid-acting antidepressant. The brain signal, detectable by noninvasive imaging, also holds clues to the agent's underlying mechanism, which are vital for drug development, say National Institutes of Health researchers.

7 Aug 2012

Geisel professor concerned about steroid abuse by adolescents

Leslie Henderson is concerned about steroid abuse, not necessarily by sports luminaries like Barry Bonds and Mark McGwire, but rather by adolescents.

7 Aug 2012

Commercial cattle vaccine can effectively reduce levels of E. coli by more than 50%

A commercial vaccine for cattle can effectively reduce levels of E. coli by more than 50 percent, a Kansas State University study has found. The vaccine is also effective using two doses instead of the recommended three doses, which can help cut costs for the beef industry.

7 Aug 2012

Studies in mice reveal how mood-altering drugs may affect brain stem cells

Working with mice, Johns Hopkins researchers say they have figured out how stem cells found in a part of the brain responsible for learning, memory and mood regulation decide to remain dormant or create new brain cells. Apparently, the stem cells "listen in" on the chemical communication among nearby neurons to get an idea about what is stressing the system and when they need to act.

7 Aug 2012

ABP, Alembic enter into development and license agreement for Accu-Break tablet technologies

Accu-Break Pharmaceuticals, Inc. announced today that it has entered into a development and license agreement with Alembic Pharmaceuticals Limited of Gujarat, India to develop new brand products that will use ABP's innovative Accu-Break tablet technologies.

6 Aug 2012

Common anti-angina drug may help protect the heart against carbon monoxide poisoning

An international research team, led from the University of Leeds, has found that a common anti-angina drug could help protect the heart against carbon monoxide poisoning.

6 Aug 2012

Qualitest confirms launch of generic Singulair Tablets for asthma and allergic rhinitis

Qualitest Pharmaceuticals today confirmed that it has launched a generic version of Singulair (montelukast sodium) Tablets and Chewable Tablets, following the expiration of the last patent that provides Merck U.S. market exclusivity. Qualitest will begin shipping the product immediately. Montelukast Sodium Tablets are labeled for use in treating symptoms of asthma and allergic rhinitis.

6 Aug 2012

Nanobiotix, PharmaEngine partner to develop NBTXR3 for cancer

French Nanobiotix S.A. announced today that it entered into a strategic partnership with PharmaEngine, Inc. for the rapid development of NBTXR3, the lead product from the NanoXray pipeline of Nanobiotix.

6 Aug 2012

Mylan receives final FDA approval for generic Amidate ANDA

Mylan Inc. today announced that its business Mylan Institutional has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Etomidate Injection USP, 2 mg/mL packaged in 40 mg/20 mL single-use vials.

6 Aug 2012

Mylan launches 18 antiretroviral products in India to treat HIV/AIDS

Mylan Inc., one of the world's leading generic and specialty pharmaceutical companies, today announced that its subsidiary, Mylan Pharmaceuticals Private Limited, has commenced commercial operations in India, starting with the launch of a comprehensive portfolio of 18 antiretroviral (ARV) products for the treatment of HIV/AIDS.

6 Aug 2012

Aquapharm discovers new antibiotic compound against multi-drug resistant bacteria

A significant discovery in the development of next-generation antibiotics has been made by Scottish biotechnology company Aquapharm.

6 Aug 2012

Medicines with the same active ingredient and size of dose will work the same in the body

In the wake of reports that a number of medicines will increase in price this week, NPS MedicineWise is reminding Australians that while the cost of a medicine may differ from brand to brand, if the active ingredient and size of the dose are the same then the medicine will work the same in their body.

6 Aug 2012

Pharmaceutical News

Dieters experience drops in basal metabolic rate, in spite of daily exercise

New class of drugs reduces adverse effects of cellular damage from cancer chemotherapy

Review explores whether HPV vaccination of young men is warranted and cost effective

Older men with higher levels of free testosterone more likely to develop prostate cancer

BioDiem granted European patent for antimicrobial drug

Mylan receives final FDA approval for Montelukast Sodium Tablets ANDA

Cannabis-based medications prove effective in relieving pain

NCH conducts workshop to teach participants how and when to use EpiPen

Scientists discover biological marker that may help identify patients’ response to antidepressants

Geisel professor concerned about steroid abuse by adolescents

Commercial cattle vaccine can effectively reduce levels of E. coli by more than 50%

Studies in mice reveal how mood-altering drugs may affect brain stem cells

ABP, Alembic enter into development and license agreement for Accu-Break tablet technologies

Common anti-angina drug may help protect the heart against carbon monoxide poisoning

Qualitest confirms launch of generic Singulair Tablets for asthma and allergic rhinitis

Nanobiotix, PharmaEngine partner to develop NBTXR3 for cancer

Mylan receives final FDA approval for generic Amidate ANDA

Mylan launches 18 antiretroviral products in India to treat HIV/AIDS

Aquapharm discovers new antibiotic compound against multi-drug resistant bacteria

Medicines with the same active ingredient and size of dose will work the same in the body

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News